The National Institute for Health and Care Excellence (NICE) has approved teplizumab for use on the NHS for people with early-stage type 1 diabetes, marking the start of a new era in how we treat the ...

Dr Elizabeth Robertson, Diabetes UK's Director of Research and Clinical, shares her thoughts following the historic approval of the first type 1 diabetes immunotherapy on the NHS.

Type 2 diabetes causes Type 2 diabetes is high blood sugar levels caused by a lack of a hormone called insulin. Either your body isn’t making enough or the insulin it makes doesn’t work properly. This ...

What is the main treatment for type 2 diabetes? The main treatments for managing blood sugar levels if you have type 2 diabetes are: ...

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...

Everything you need to know about type 2 diabetes remission. Find out what type 2 diabetes remission is, how it works, and what the benefits are.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Our new analysis predicts that, without significant government action, up to 5.5m people in the UK could be living with diabetes by 2030.

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...

UPDATE, 22 MAY 2024: We now have new information on the amount of people living with the diabetes, and for more information you can visit our guide on diabetes statistics. The number of people living ...

A new analysis has revealed that approximately 30% of people living with type 2 diabetes in England, or around one million adults, are undiagnosed. And around one in nine of all adults in England are ...